Screener
Cronos Group CRON Cannabis flower — Net revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cronos Group in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Cronos Group’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001656472-26-000051
FAQ
- What is Cronos Group's cannabis flower — net revenue?
- Cronos Group (CRON) reported cannabis flower — net revenue of $39.21M in Q2 2026.
- How has Cronos Group's cannabis flower — net revenue changed year-over-year?
- Cronos Group's cannabis flower — net revenue increased by 56.7% year-over-year, from $25.03M to $39.21M.
- What is the long-term trend for Cronos Group's cannabis flower — net revenue?
- Over 4 years (2021 to 2025), Cronos Group's cannabis flower — net revenue has grown at a 18.4% compound annual growth rate (CAGR), from $55.19M to $108.48M.
- What does cannabis flower — net revenue mean?
- This metric represents the total net revenue generated from the sale of dried cannabis flower products across both medicinal and recreational brands. It serves as a primary indicator of consumer demand and market penetration for the company's core cannabis product line. Tracking this revenue stream helps investors evaluate the growth trajectory and competitive positioning of the company's flagship product offerings within the regulated cannabis market.
Ask your AI about Cronos Group's cannabis flower — net revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude